63 results
8-K
EX-10.1
BCLI
Brainstorm Cell Therapeutics, Inc.
19 Jul 23
Brainstorm Cell Therapeutics Announces Pricing of $7.5 Million Registered Direct Offering
4:05pm
an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding, such as a deposition … Reports, there is no action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of the Company, threatened
8-K
EX-10.2
BCLI
Brainstorm Cell Therapeutics, Inc.
19 Jul 23
Brainstorm Cell Therapeutics Announces Pricing of $7.5 Million Registered Direct Offering
4:05pm
by the other party for its reasonable attorney's fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action
8-K
EX-99.1
bbssz4jvyg31457idn
30 Mar 23
BrainStorm Cell Therapeutics Announces Full Year 2022 Financial Results and Provides a Corporate Update
7:18am
8-K
EX-99.1
pe4ty7h077bs newkj
14 Nov 22
BrainStorm Cell Therapeutics Announces Third Quarter 2022 Financial Results and Provides a Corporate Update
7:15am
8-K
EX-99.1
kg87h0eqzx yc
15 Aug 22
BrainStorm Cell Therapeutics Announces Second Quarter 2022 Financial Results and Provides a Corporate Update
7:22am